Roles of plasma proteins in mediating the causal effect of the lipid species on gastric cancer and exploring potential drug targets for gastric cancer:insights from proteomic and two-step mendelian randomization and macromolecular docking

Zhenhua Dong, Zhiqing Chen, Dingling Zhao, Jianling Jia, Hongliang Cao, Pengyu Wang, Kai Yu, Xulei Gao, Daguang WangResearch Square 2024 · DOI

Abstract

Gastric cancer (GC) remains a significant global health burden with complex etiology. While lipid species are known to be associated with GC risk, the underlying biological mechanisms remain poorly understood. This study utilizes a multi-omics approach, combining two-step Mendelian randomization (MR), summary-data-based MR (SMR), and macromolecular docking to identify plasma proteins that mediate the causal effect of lipids on GC. Our analysis identified CCDC80 as a key mediator, accounting for approximately 31% of the causal effect of specific diacylglycerols on GC risk. Furthermore, computational docking identified several potential small-molecule ligands for CCDC80, suggesting its potential as a novel therapeutic target.

Introduction

Gastric cancer (GC) is a leading cause of cancer-related mortality worldwide. Observational studies have long suggested a link between blood lipid levels and cancer risk, but establishing causality is difficult due to confounding factors and reverse causation. Identifying the specific plasma proteins that translate lipid signals into oncogenic processes is essential for developing targeted interventions. This study aims to bridge this gap by using genetic causal inference to map the pathways between the lipidome, the proteome, and GC risk.

Methods

Researchers employed a sophisticated "multi-omics" workflow to identify causal pathways:

  • Two-Step Mendelian Randomization (MR): Genetic variants were used as instrumental variables to determine if lipids (exposure) cause GC (outcome) through specific plasma proteins (mediators).
  • SMR and Colocalization: These techniques were used to ensure that the genetic signals driving protein expression and GC risk were identical, reducing the risk of pleiotropy.
  • Mediation Analysis: The propagation of error method was used to quantify the proportion of the lipid-to-cancer effect mediated by specific proteins.
  • Macromolecular Docking: Once a target protein (CCDC80) was identified, AutoDock Vina was used to simulate the binding stability of potential small-molecule ligands.

The study leveraged large-scale datasets, including the decode2021 and UKBppp proteomics datasets (over 89,000 combined subjects), lipidomics data from the GeneRISK cohort, and GC summary statistics from the IEU catalog (7,921 cases).

Results

Causal Associations

The MR analysis identified significant causal links between 12 lipid species and GC risk. Additionally, three proteins—CCDC80, PDCD1LG2, and IGFALS—showed causal associations with GC. CCDC80 (Coiled-Coil Domain Containing 80) was identified as a protective factor, where higher genetically predicted levels were associated with a lower risk of GC.

Mediation Effect

A critical finding was that CCDC80 mediates 30.8% (95% CI: 6.4%–64.0%) of the causal effect of Diacylglycerol (16:1_18:1) on gastric cancer. This suggests that certain lipid species influence cancer risk specifically by modulating the levels of this protective secreted protein.

Potential Drug Targets

To explore the therapeutic potential of CCDC80, macromolecular docking was performed. Four ligands showed stable binding affinities (all < -4.9 kcal/mol):

  • 2,3,7,8-Tetrachlorodibenzo-P-dioxin (-5.51 kcal/mol)
  • Benzo[a]pyrene
  • Bisphenol A
  • Valproic Acid

Discussion

CCDC80 is a secreted plasma protein involved in cell adhesion and tumor suppression. Its role as a mediator suggests that maintaining or increasing CCDC80 levels could mitigate the pro-carcinogenic effects of specific lipid profiles. While the computational docking results are promising, particularly for established compounds like Valproic Acid, these findings require rigorous in vitro and in vivo validation.

Conclusion

This study provides genetic evidence that CCDC80 is a key mediator in the lipid-gastric cancer axis. By identifying the specific lipid species and proteins involved, this research offers a clearer roadmap for the development of targeted therapies and risk-stratification strategies for gastric cancer.

Summary updated

Abstract

<title>Abstract</title> <bold>Background</bold> The change of plasma lipid species has close contacts with gastric cancer (GC). However, the specific mechanism still needs to explore further. <bold>Objectives</bold> We aim to utilize plasma proteins to decipher the association between lipid species and GC, and seek possible drug targets for GC. <bold>Methods</bold> A two-step mendelian randomization (MR) is conducted to identify the causal relationship among 179 lipid species, 4907 plasma proteins and GC. We employ the summary mendelian randomization (SMR) and colocalization to explore relationship between plasma proteins and GC. We use one protein data including 35559 individuals as discovery group, meanwhile the other one from 54219 subjects as validation group. MR is performed to identify the association between lipid species and GC or plasma proteins. Based on chosen proteins, we use macromolecular docking to find potential components as ligands. <bold>Results</bold> MR identifies the causality between 12 lipid species and GC, 3 proteins and GC, 2 lipid species and 2 proteins. After the test of propagation of error method, we conclude that CCDC80 protein mediates (30.8%; 95% confidents interval (Cl), 6.4%-64.0%) of the association between Diacylglycerol (16:1_18:1) and GC. For CCDC80, we choose 4 components including 2,3,7,8-Tetrachlorodibenzo-P-dioxin, Benzo[a]pyrene, Bisphenol A, Valproic Acid as potential drugs. <bold>Conclusion</bold> Our study suggests that CCDC80, a drug target, is a mediator between Diacylglycerol (16:1_18:1) and GC, which may guide a novel direction for GC treatment.
BibTeX
@inproceedings{dong2024roles,
  author = {Zhenhua Dong and Zhiqing Chen and Dingling Zhao and Jianling Jia and Hongliang Cao and Pengyu Wang and Kai Yu and Xulei Gao and Daguang Wang},
  title = {{Roles of plasma proteins in mediating the causal effect of the lipid species on gastric cancer and exploring potential drug targets for gastric cancer:insights from proteomic and two-step mendelian randomization and macromolecular docking}},
  booktitle = {Research Square},
  year = {2024},
  doi = {10.21203/rs.3.rs-4574875/v1},
}
Figure